Products
Practicing Green Pharmaceutical Manufacturing
Contributing to Healthy China
Contributing to Healthy China
Allergic Diseases
Infectious Diseases
Our team focuses on scientific target engagement to discover novel drug targets, driving the innovative development of original drugs. Our current portfolio spans the immunotherapy and antiviral fields, covering diseases such as HIV, genital herpes, and chronic spontaneous urticaria.
Compared to conventional IgG antibodies, our products feature a defucosylation design. By removing fucose from the glycan structure, we enhance the original antibody-dependent cellular cytotoxicity (ADCC) by more than 10-fold, without affecting complement-dependent cytotoxicity (CDC), thereby significantly improving monoclonal antibody therapeutic efficacy.
Genesis Life Science WeChat
Genesis Life Science LinkedIn
ZipCode:222500
Tel.:(0514)82222527
Headquarters (Yangzhou): No.2 Jiankang 1st Road, Yangzhou Hi-Tech Zone,
Hanjiang District, Yangzhou City, Jiangsu Province